303 related articles for article (PubMed ID: 36369093)
61. High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies.
van der Steeg WA; Holme I; Boekholdt SM; Larsen ML; Lindahl C; Stroes ES; Tikkanen MJ; Wareham NJ; Faergeman O; Olsson AG; Pedersen TR; Khaw KT; Kastelein JJ
J Am Coll Cardiol; 2008 Feb; 51(6):634-42. PubMed ID: 18261682
[TBL] [Abstract][Full Text] [Related]
62. ApoB/ApoA-I ratio is independently associated with carotid atherosclerosis in type 2 diabetes mellitus with well-controlled LDL cholesterol levels.
Jun JE; Choi YJ; Lee YH; Kim DJ; Park SW; Huh BW; Lee EJ; Jee SH; Hur KY; Choi SH; Huh KB
Korean J Intern Med; 2018 Jan; 33(1):138-147. PubMed ID: 29334727
[TBL] [Abstract][Full Text] [Related]
63. Cholesterol not particle concentration mediates the atherogenic risk conferred by apolipoprotein B particles: a Mendelian randomization analysis.
Helgadottir A; Thorleifsson G; Snaebjarnarson A; Stefansdottir L; Sveinbjornsson G; Tragante V; Björnsson E; Steinthorsdottir V; Gretarsdottir S; Helgason H; Saemundsdottir J; Olafsson I; Thune JJ; Raja AA; Ghouse J; Olesen MS; Christensen A; Jacobsen RL; Dowsett J; Bruun MT; Nielsen K; Knowlton K; Nadauld L; Benediktsson R; Erikstrup C; Pedersen OB; Banasik K; Brunak S; ; Bundgaard H; Ostrowski SR; Sulem P; Arnar DO; Thorgeirsson G; Thorsteinsdottir U; Gudbjartsson DF; Stefansson K; Holm H
Eur J Prev Cardiol; 2022 Dec; 29(18):2374-2385. PubMed ID: 36125206
[TBL] [Abstract][Full Text] [Related]
64. Association of Genetically Predicted Lipid Levels With the Extent of Coronary Atherosclerosis in Icelandic Adults.
Björnsson E; Thorleifsson G; Helgadóttir A; Guðnason T; Guðbjartsson T; Andersen K; Grétarsdóttir S; Ólafsson Í; Tragante V; Ólafsson ÓH; Jónsdóttir B; Eyjólfsson GI; Sigurðardóttir Ó; Thorgeirsson G; Guðbjartsson DF; Thorsteinsdóttir U; Hólm H; Stefánsson K
JAMA Cardiol; 2020 Jan; 5(1):13-20. PubMed ID: 31746962
[TBL] [Abstract][Full Text] [Related]
65. Plasma lipoprotein composition in alcoholic hepatitis: accumulation of apolipoprotein E-rich high density lipoprotein and preferential reappearance of "light'-HDL during partial recovery.
Weidman SW; Ragland JB; Sabesin SM
J Lipid Res; 1982 May; 23(4):556-69. PubMed ID: 7097121
[TBL] [Abstract][Full Text] [Related]
66. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy.
Cubrilo-Turek M; Sertić J; Duraković Z
Acta Med Croatica; 2001; 55(4-5):161-7. PubMed ID: 12398019
[TBL] [Abstract][Full Text] [Related]
67. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.
Pischon T; Girman CJ; Sacks FM; Rifai N; Stampfer MJ; Rimm EB
Circulation; 2005 Nov; 112(22):3375-83. PubMed ID: 16316964
[TBL] [Abstract][Full Text] [Related]
68. Combining beta-adrenergic and peroxisome proliferator-activated receptor gamma stimulation improves lipoprotein composition in healthy moderately obese subjects.
Hughes TA; Stentz F; Gettys T; Smith SR
Metabolism; 2006 Jan; 55(1):26-34. PubMed ID: 16324916
[TBL] [Abstract][Full Text] [Related]
69. Changes in the atherogenic profile of patients with type 1 Gaucher disease after miglustat therapy.
Puzo J; Alfonso P; Irun P; Gervas J; Pocovi M; Giraldo P
Atherosclerosis; 2010 Apr; 209(2):515-9. PubMed ID: 19959168
[TBL] [Abstract][Full Text] [Related]
70. Sex-specific differences in blood lipids and lipid ratios in type 2 diabetic foot patients.
Yin S; Zhao P; Ai Z; Deng B; Jia W; Wang H; Zheng J
J Diabetes Investig; 2021 Dec; 12(12):2203-2211. PubMed ID: 34137504
[TBL] [Abstract][Full Text] [Related]
71. Triglyceride to High-Density Lipoprotein Cholesterol Ratio and Cardiovascular Events in Diabetics With Coronary Artery Disease.
Yang SH; Du Y; Li XL; Zhang Y; Li S; Xu RX; Zhu CG; Guo YL; Wu NQ; Qing P; Gao Y; Cui CJ; Dong Q; Sun J; Li JJ
Am J Med Sci; 2017 Aug; 354(2):117-124. PubMed ID: 28864368
[TBL] [Abstract][Full Text] [Related]
72. [Lipid variations in coronary disease].
Biagi R; Rossi L; Guidotti P; Battista P; Toschi P; Rovinetti C
Boll Soc Ital Biol Sper; 1982 Aug; 58(15):940-6. PubMed ID: 7126368
[TBL] [Abstract][Full Text] [Related]
73. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
Tani S; Nagao K; Hirayama A
Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
[TBL] [Abstract][Full Text] [Related]
74. The effect of aggressive and moderate lowering of LDL-cholesterol and low dose anticoagulation on plasma lipids, apolipoproteins and lipoprotein families in post coronary artery bypass graft trial.
Alaupovic P; Fesmire JD; Hunnighake D; Domanski M; Forman S; Knatterud GL; Forrester J; Herd JA; Hoogwerf B; Campeau L; Gobel FL
Atherosclerosis; 1999 Oct; 146(2):369-79. PubMed ID: 10532693
[TBL] [Abstract][Full Text] [Related]
75. [Establishment of a nomogram prediction model for coronary artery disease risk in elderly patients with acute myocardial infarction].
Yang Y; Yang D; Zhao W; He X; Wang X; Wang J; Liu F; Meng Q
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Aug; 33(8):967-972. PubMed ID: 34590565
[TBL] [Abstract][Full Text] [Related]
76. Lipid profile, lipid ratios, apolipoproteins, and risk of cardiometabolic multimorbidity in men: The Kuopio Ischaemic Heart Disease Risk Factor Study.
Tajik B; Voutilainen A; Kauhanen J; Mazidi M; Lip GYH; Tuomainen TP; Isanejad M
Lipids; 2022 Mar; 57(2):141-149. PubMed ID: 35049039
[TBL] [Abstract][Full Text] [Related]
77. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study.
Walldius G; Jungner I; Holme I; Aastveit AH; Kolar W; Steiner E
Lancet; 2001 Dec; 358(9298):2026-33. PubMed ID: 11755609
[TBL] [Abstract][Full Text] [Related]
78. Cholesterol pathway biomarkers are associated with neuropsychological measures in multiple sclerosis.
Siddiqui K; Browne RW; Benedict RHB; Jakimovski D; Weinstock-Guttman B; Zivadinov R; Ramanathan M
Mult Scler Relat Disord; 2023 Jan; 69():104374. PubMed ID: 36403378
[TBL] [Abstract][Full Text] [Related]
79. Pitavastatin: novel effects on lipid parameters.
Chapman MJ
Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
[TBL] [Abstract][Full Text] [Related]
80. Lipoprotein predictors of cardiovascular events in statin-treated patients with coronary heart disease. Insights from the Incremental Decrease In End-points Through Aggressive Lipid-lowering Trial (IDEAL).
Holme I; Cater NB; Faergeman O; Kastelein JJ; Olsson AG; Tikkanen MJ; Larsen ML; Lindahl C; Pedersen TR;
Ann Med; 2008; 40(6):456-64. PubMed ID: 19160529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
